In recent years, endovascular procedures have become the treatment of choice for thoracic and certain types of thoracoabdominal aortic aneurysms (TAAAs). The most common contraindications for endografting of the thoracic aorta is an insufficient amount of proximal and distal sealing zones and the failure to introduce the graft through the femoral artery. We report here the successful endografting of a Crawford type 1 TAAA with infrarenal occlusion of the aorta.
CASE REPORT
A 62-year-old male patient was admitted to our hospital with severe back pain and a previous diagnosis of type 1 TAAA. He also had suffered from severe bilateral thigh, buttock, and calf claudication for several years. The patient was operated on in another hospital for his infrarenal aortic occlusion and underwent an aortobifemoral bypass graft via a retroperitoneal approach two weeks prior to being admitted to our facility. His medical history was notable for severe chronic obstructive pulmonary disease (COPD), hypertension, and congestive heart failure, and he also had a hostile abdomen because of multiple previous abdominal operations. Computed tomography (CT) angiography and intra-arterial digital subtraction angiography (DSA) (Figure 1a , b) revealed a 11 cm type 1 TAAA extending from the middle of the descending aorta that was 1.2 cm proximal to the celiac artery. In addition, the patient's infrarenal aorta was stenotic proximal to his new aortobifemoral graft. Given the comorbid conditions, we decided that endovascular treatment was appropriate. Due to his new aortobifemoral graft, stenosis proximal to this graft, and the distance to the celiac artery, we performed the procedure through the ascending aorta in an antegrade fashion in the cardiovascular surgery operating room with a mobile Avantic C-Arm (Siemens AG, Erlangen, Germany). Under general anesthesia, a median sternotomy was performed, and 5000 IU of heparin was given intravenously. A 10 mm Dacron graft was then sewn to the ascending aorta. An 8F introducer was placed through the Dacron graft, and a hydrophilic 0.035 inch guidewire (Terumo Medical Corporation, Tokyo, Japan) was advanced 
DISCUSSION
The first successful open repair of a thoracic aortic aneurysm was reported in 1953 by DeBakey and Cooley, and the introduction of thoracic endovascular aortic repair (TEVAR) for the descending thoracic aorta was reported by Dake et al. [1] in 1994. Since then, several reports have described the intermediateterm outcomes of TEVAR. [2] These have been generally promising with the early benefits of decreased morbidity and mortality compared with open repair. [3, 4] However, the use of endovascular techniques for TAAAs still has limited applications due to difficulties with blood flow preservation in the renal and visceral arteries. Another major problem with endografting is the presence of adverse features in an individual's vascular anatomy, such as stenosis in the iliac arteries. [5] Recently fenestrated devices and hybrid procedures, including visceral bypass grafting combined with endografting, have been applied to eliminate the risks associated with conventional surgical repair in difficult cases. [6] Whereas the management of stenotic iliac arteries in endografting is still controversial, dilating these arteries with covered stents prior to endografting along with direct retroperitoneal iliac conduits have been used successfully in some cases. Our patient also received a retroperitoneal aortobifemoral graft 15 days prior to his admission to our center. Given that his recent surgery and calcifications were proximal to his new graft, we decided not to attempt to deliver the graft via the femoral route.
One of the most common exclusion criterias for endografting of the thoracic aorta is an insufficient proximal and/or distal sealing zone. The minimal safe sealing length in the thoracic aorta is 2 cm. In the proximal end, the sealing zone can be extended by covering the left subclavian artery, and this can be achieved with or without a carotid-subclavian bypass.
In the distal end, the distance between the celiac artery and aneurysm also becomes an important issue. Most stent grafts are deployed from the proximal end by retracting an outer sheath, and it is difficult to predict exactly where the distal margin of the stent graft is going to land. Therefore, we thought that we would have a better chance of preserving the patient's celiac artery if we attempted to deliver the graft through the ascending aorta in a retrograde manner and open the graft from the distal end. [7] To our knowledge, this is the first case in the literature in which a sternotomy was used as an access route in the case of extensive calcified atherosclerotic disease of the infrarenal abdominal aorta. We did not attempt to use the subclavian artery for such a large introducer sheath with the current devices. Another option might have been to use a partial sternotomy instead of a full sternotomy.
In conclusion, endovascular treatment of aortic aneurysms in the setting of severe peripheral arterial disease is not a common occurrence. The complex iliac anatomy continues to be a limiting factor and carries a risk of complication that includes hemorrhage, rupture, and dissection. Our case illustrates the feasibility of placing an endograft via the ascending aorta, which safely and effectively controlled the possible complications in our patient. In addition, this procedure also allows for the precise placement of the distal landing zone in aneurysms near the visceral arteries.
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